X0306 4 2020-07-28 0 0001549595 Nurix Therapeutics, Inc. NRIX 0001817230 Tjian Robert C/O NURIX THERAPEUTICS, INC. 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 1 0 0 0 Common Stock 2020-07-28 4 C 0 41666 A 74999 I By Trust Common Stock 2020-07-28 4 C 0 50000 A 124999 I By Trust Series A-2 Preferred Stock 2020-07-28 4 C 0 41666 0.00 D Common Stock 41666 0 I By Trust Series B Preferred Stock 2020-07-28 4 C 0 50000 0.00 D Common Stock 50000 0 I By Trust The Series A-2 and Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering and had no expiration date. The Reporting Person is a trustee of the Tjian Belcher Revocable Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes. /s/ Christine Ring, as Attorney-in-Fact for Robert Tjian 2020-07-29